This is a beta version of OpenPrescribing Hospitals for testing and feedback purposes. Data and functionality may be incomplete. Please contact us if you find any issues or have feedback. Sign up for email alerts to stay updated.
This measure supports medicines safety work to reduce risk and minimise mistakes in hospitals.
Total count of insulin detemir pre-filled devices / cartridges issued.
We display the total number of insulin detemir pre-filled devices / cartridges issued.
Novo Nordisk are discontinuing all formulations of Levemir®, the only insulin detemir product available in the UK, with supply due to exhaust by December 2026.
The Primary Care Diabetes & Obesity Society (PCDOS) and Association of British Clinical Diabetologists (ABCD) have written guidance to support clinicians in selecting and safely initiating alternative basal insulins. The guidance recommends that local teams diversify prescribing across the available options to reduce supply risks. Given the significant regional variation in prescribing, it also advises using data to support planning.
This OpenPrescribing Hospitals measure, alongside it’s primary care OpenPrescribing counterpart provides data on variation across primary and secondary care to support this planning.
Trusts are only included in this measure if they have issued any products included in the denominator for this measure.
For this measure, 221/227 Trusts are included. A full list of Trusts included is available on the Submission History page.